![]() | |
Names | |
---|---|
IUPAC name 1H-benzo[g]pteridine-2,4-dione | |
Other names 1,2,3,4-Tetrahydrobenzopteridine-2,4-dione; Benzo(g)pteridine-2,4(1H,3H)-dione | |
Identifiers | |
3D model (JSmol) | |
85819 | |
ChEBI | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.007.014 |
EC Number |
|
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
| |
| |
Properties | |
C10H6N4O2 | |
Molar mass | 214.184 g·mol−1 |
Appearance | Red solid |
Melting point | 200 °C (392 °F; 473 K) [1] |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
Isoalloxazine is the structural foundation of flavins such as riboflavin (vitamin B2) and is a heterocyclic compound. [2] It has a tricyclic structure which means it has three interconnected rings of atoms and is a tautomer of alloxazine. [1] The structure is formed by primary-secondary aromatic o-diamines and they are a high-melting crystalline substance. [1] The R-group is used to attach various flavin groups It has a similar structure to pteridines which has two interconnected rings. [1] Isoalloxazine was first obtained in 1934 [1] by Richard Kuhn an Austrian-German biochemist and lab mates.
Isoalloxazine rings can exist in different redox and ionization states depending on the chemistry of FMN and FAD associated with it. [3] Using the redox-active isoalloxazine system, FAD and FMN are able to do one and two electron transfer reactions and also be coupled with proton transfers. [4]